United States · Funded startup
6 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$75Mraised across 6 rounds since 2005, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $2.0M sold, first sale Dec 2011
No investor was named in the report.
Reported by sec.govSEC filing: $995K sold, first sale Jul 2011
No investor was named in the report.
Reported by sec.govSEC filing: $995K sold, first sale Jul 2011
Reported by venturedeal.com
Bay City Capital
Pappas VenturesReported by venturebeat.com
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Bay City CapitalOxford Bioscience PartnersNeuroVentures
New Enterprise Associates
Alexandria Real Estate EquitiesTechnology PartnersMedImmune VenturesPappas Ventures
A. M. Pappas & AssociatesMissing a round, or an investor who was in one? Tell us.
BrainCells's investors include Bay City Capital, Oxford Bioscience Partners, NeuroVentures, New Enterprise Associates and Alexandria Real Estate Equities, and 4 more on record.
BrainCells has raised $75M across 6 rounds since 2005.
BrainCells's most recent round was a Debt of $2.0M in Jan 2012.
BrainCells's largest round on record is $30M (Series B), in Mar 2008.
BrainCells's first round on record, in Jul 2005, was backed by Bay City Capital, Oxford Bioscience Partners and A. M. Pappas & Associates and 1 others.
BrainCells's latest named round is a Debt, in Jan 2012.
BrainCells is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·